Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany

Drug budget and prescription control measures are implemented regionally in Germany, meaning that the uptake of pharmaceuticals, including biosimilars, can vary by region. We examine regional market dynamics of tumor necrosis factor alpha (TNFα) inhibitor originators and biosimilars in Germany and s...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Evelien Moorkens, Teresa Barcina Lacosta, Arnold G. Vulto, Martin Schulz, Gabriele Gradl, Salka Enners, Gisbert Selke, Isabelle Huys, Steven Simoens
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI AG 2020-10-01
Serie:Pharmaceuticals
Soggetti:
infliximab
etanercept
TNFα inhibitors
biologics
biosimilars
Germany
Accesso online:https://www.mdpi.com/1424-8247/13/10/324
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi